For example, Dao et al. and Engelhard et al. highlighted the importance of cancer-specific phosphopeptides (p-peptides), such as those derived from insulin receptor substrate 2 (pIRS21097–1105) and breast cancer antiestrogen resistance 3 (pBCAR3126–134), as viable targets for cancer immunotherapy [19,20]. This evidence concerns the gene IRS2 and cancer.